These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 17003773

  • 1. A comparison of dual energy X-ray absorptiometry of the hip and accuDEXA of the finger for the diagnosis of osteoporosis in men on androgen deprivation therapy for advanced prostate cancer.
    Bae DC, Leocádio DE, Stein BS.
    Prostate Cancer Prostatic Dis; 2007; 10(1):94-6. PubMed ID: 17003773
    [Abstract] [Full Text] [Related]

  • 2. Peripheral or axial bone density measurements to identify osteoporosis in prostate cancer patients undergoing androgen deprivation therapy?
    Wadhwa VK, Parr NJ.
    Urology; 2009 Jun; 73(6):1347-51. PubMed ID: 19362345
    [Abstract] [Full Text] [Related]

  • 3. Osteoporosis in men with prostate carcinoma receiving androgen-deprivation therapy: recommendations for diagnosis and therapies.
    Diamond TH, Higano CS, Smith MR, Guise TA, Singer FR.
    Cancer; 2004 Mar 01; 100(5):892-9. PubMed ID: 14983482
    [Abstract] [Full Text] [Related]

  • 4. Age, body mass index, and serum prostate-specific antigen correlate with bone loss in men with prostate cancer not receiving androgen deprivation therapy.
    Conde FA, Sarna L, Oka RK, Vredevoe DL, Rettig MB, Aronson WJ.
    Urology; 2004 Aug 01; 64(2):335-40. PubMed ID: 15302490
    [Abstract] [Full Text] [Related]

  • 5. Quantitative ultrasound of the heel as triage test to measure bone mineral density compared with dual energy X-ray absorptiometry in men with prostate cancer commencing with androgen deprivation therapy.
    van Casteren-Messidoro C, Huisman AM, Birnie E, van Gelder M, van de Geijn FE, Hamberg P.
    Neth J Med; 2014 Dec 01; 72(10):528-32. PubMed ID: 26219758
    [Abstract] [Full Text] [Related]

  • 6. Prevalence of osteopenia and osteoporosis by central and peripheral bone mineral density in men with prostate cancer during androgen-deprivation therapy.
    Bruder JM, Ma JZ, Basler JW, Welch MD.
    Urology; 2006 Jan 01; 67(1):152-5. PubMed ID: 16413352
    [Abstract] [Full Text] [Related]

  • 7. [Influence of androgen deprivation therapy on bone mineral density in men with prostate cancer].
    Deng J, Li W, Yang L, Wang L, Zou D.
    Zhonghua Nan Ke Xue; 2004 Oct 01; 10(10):761-3. PubMed ID: 15562791
    [Abstract] [Full Text] [Related]

  • 8. Clinical evaluation of a phalangeal bone mineral density assessment system.
    Patel R, Blake GM, Panayiotou E, Fogelman I.
    J Clin Densitom; 2010 Oct 01; 13(3):292-300. PubMed ID: 20554233
    [Abstract] [Full Text] [Related]

  • 9. Progressive decrease in bone density over 10 years of androgen deprivation therapy in patients with prostate cancer.
    Kiratli BJ, Srinivas S, Perkash I, Terris MK.
    Urology; 2001 Jan 01; 57(1):127-32. PubMed ID: 11164157
    [Abstract] [Full Text] [Related]

  • 10. Randomized, double-blinded, placebo-controlled, trial of risedronate for the prevention of bone mineral density loss in nonmetastatic prostate cancer patients receiving radiation therapy plus androgen deprivation therapy.
    Choo R, Lukka H, Cheung P, Corbett T, Briones-Urbina R, Vieth R, Ehrlich L, Kiss A, Danjoux C.
    Int J Radiat Oncol Biol Phys; 2013 Apr 01; 85(5):1239-45. PubMed ID: 23265571
    [Abstract] [Full Text] [Related]

  • 11. Alendronate decreases the fracture risk in patients with prostate cancer on androgen-deprivation therapy and with severe osteopenia or osteoporosis.
    Planas J, Trilla E, Raventós C, Cecchini L, Orsola A, Salvador C, Placer J, Encabo G, Morote J.
    BJU Int; 2009 Dec 01; 104(11):1637-40. PubMed ID: 19549260
    [Abstract] [Full Text] [Related]

  • 12. Long-term changes in bone mineral density and predicted fracture risk in patients receiving androgen-deprivation therapy for prostate cancer, with stratification of treatment based on presenting values.
    Wadhwa VK, Weston R, Mistry R, Parr NJ.
    BJU Int; 2009 Sep 01; 104(6):800-5. PubMed ID: 19338564
    [Abstract] [Full Text] [Related]

  • 13. Bone health management in prostate cancer patients receiving androgen deprivation therapy.
    Dhanapal V, Reeves DJ.
    J Oncol Pharm Pract; 2012 Mar 01; 18(1):84-90. PubMed ID: 21807761
    [Abstract] [Full Text] [Related]

  • 14. Osteoporosis and prostate cancer: a cross-sectional study of Danish men with prostate cancer before androgen deprivation therapy.
    Poulsen MH, Frost M, Abrahamsen B, Brixen K, Walter S.
    Scand J Urol; 2014 Aug 01; 48(4):350-5. PubMed ID: 24548220
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of bone mass density on patients with prostate cancer prior to the start of androgen deprivation therapy.
    Ziaran S, Goncalves FM, Wendl J, Trebaticky B, Breza JS.
    Bratisl Lek Listy; 2009 Aug 01; 110(9):559-62. PubMed ID: 19827339
    [Abstract] [Full Text] [Related]

  • 16. Comparison of fracture risk assessment tool score to bone mineral density for estimating fracture risk in patients with advanced prostate cancer on androgen deprivation therapy.
    James H, Aleksic I, Bienz MN, Pieczonka C, Iannotta P, Albala D, Mariados N, Mouraviev V, Saad F.
    Urology; 2014 Jul 01; 84(1):164-8. PubMed ID: 24976229
    [Abstract] [Full Text] [Related]

  • 17. Androgen deprivation in men with prostate cancer is associated with an increased rate of bone loss.
    Preston DM, Torréns JI, Harding P, Howard RS, Duncan WE, McLeod DG.
    Prostate Cancer Prostatic Dis; 2002 Jul 01; 5(4):304-10. PubMed ID: 12627216
    [Abstract] [Full Text] [Related]

  • 18. Management of osteoporosis in men on androgen deprivation therapy.
    Adler RA.
    Maturitas; 2011 Feb 01; 68(2):143-7. PubMed ID: 21129866
    [Abstract] [Full Text] [Related]

  • 19. Low bone density and high percentage of body fat among men who were treated with androgen deprivation therapy for prostate carcinoma.
    Chen Z, Maricic M, Nguyen P, Ahmann FR, Bruhn R, Dalkin BL.
    Cancer; 2002 Nov 15; 95(10):2136-44. PubMed ID: 12412167
    [Abstract] [Full Text] [Related]

  • 20. The diagnosis and treatment of osteoporosis in men on androgen deprivation therapy for advanced carcinoma of the prostate.
    Bae DC, Stein BS.
    J Urol; 2004 Dec 15; 172(6 Pt 1):2137-44. PubMed ID: 15538219
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.